{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T13:21:05Z","timestamp":1773840065595,"version":"3.50.1"},"reference-count":19,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2007,2,1]],"date-time":"2007-02-01T00:00:00Z","timestamp":1170288000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Hepatology"],"published-print":{"date-parts":[[2007,2]]},"DOI":"10.1016\/j.jhep.2006.08.020","type":"journal-article","created":{"date-parts":[[2006,10,21]],"date-time":"2006-10-21T11:11:23Z","timestamp":1161429083000},"page":"206-212","source":"Crossref","is-referenced-by-count":159,"title":["Peginterferon alfa-2b and ribavirin in patients with hepatitis C virus and decompensated cirrhosis: A controlled study"],"prefix":"10.1016","volume":"46","author":[{"given":"Angelo","family":"Iacobellis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Massimo","family":"Siciliano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"Perri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brigida E.","family":"Annicchiarico","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gioacchino","family":"Leandro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nazario","family":"Caruso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Accadia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuseppe","family":"Bombardieri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angelo","family":"Andriulli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jhep.2006.08.020_bib1","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1056\/NEJM200012073432302","article-title":"Peginterferon alfa-2a in patients with chronic hepatitis C and cirrhosis","volume":"343","author":"Heathcote","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jhep.2006.08.020_bib2","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/S0168-8278(01)00005-8","article-title":"Interferon and prevention of hepatocellular carcinoma in viral cirrhosis: an evidence-based approach","volume":"34","author":"Camma","year":"2001","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2006.08.020_bib3","first-page":"296","article-title":"Determinants of outcome of compensated hepatitis C virus-related cirrhosis","volume":"28","author":"Serfaty","year":"1998","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2006.08.020_bib4","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0168-8278(97)80302-9","article-title":"Effectiveness of interferon alfa on incidence of hepatocellular carcinoma and decompensation in cirrhosis type C. European Concerted Action on viral hepatitis (EUROHEP)","volume":"27","author":"Fattovich","year":"1997","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2006.08.020_bib5","doi-asserted-by":"crossref","first-page":"346","DOI":"10.7326\/0003-4819-140-5-200403020-00010","article-title":"PEGASYS International study group. Peginterferon-alpha2a and ribavirin combination therapy in chronic hepatitis C: a randomized study of treatment duration and ribavirin dose","volume":"140","author":"Hadziyannis","year":"2004","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jhep.2006.08.020_bib6","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/S0168-8278(03)00310-6","article-title":"Antiviral therapy of patients with decompensated cirrhosis to prevent recurrence of hepatitis C after liver transplantation","volume":"39","author":"Forns","year":"2003","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2006.08.020_bib7","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1053\/jlts.2003.50166","article-title":"Infection with chronic hepatitis C virus and liver transplantation: a role for interferon therapy before transplantation","volume":"9","author":"Thomas","year":"2003","journal-title":"Liver Transpl"},{"key":"10.1016\/j.jhep.2006.08.020_bib8","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1002\/hep.20793","article-title":"Treatment of advanced hepatitis C with a low accelerating dosage regimen of antiviral therapy","volume":"42","author":"Everson","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2006.08.020_bib9","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1053\/jlts.2002.31748","article-title":"A pilot study of the tolerability and efficacy of antiviral therapy in hepatitis C virus-infected patients awaiting liver transplantation","volume":"8","author":"Crippin","year":"2002","journal-title":"Liver Transpl"},{"key":"10.1016\/j.jhep.2006.08.020_bib10","doi-asserted-by":"crossref","first-page":"644A","DOI":"10.1016\/S0270-9139(03)81051-0","article-title":"Interferon treatment outcomes in patients with decompensated HCV+ cirrhosis","volume":"38","author":"Alvarez","year":"2003","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2006.08.020_bib11","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1053\/jlts.2003.50268","article-title":"Report of the First International Liver Transplantation Society Expert Panel Consensus Conference on Liver Transplantation and Hepatitis C","volume":"9","author":"Wiesner","year":"2003","journal-title":"Liver Transpl"},{"key":"10.1016\/j.jhep.2006.08.020_bib12","doi-asserted-by":"crossref","unstructured":"National Institute of Health consensus development conference statement. Management of hepatitis C. Hepatology 2002;36:S3\u201320.","DOI":"10.1002\/hep.1840360703"},{"key":"10.1016\/j.jhep.2006.08.020_bib13","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1053\/gast.1997.v112.pm9024300","article-title":"Morbidity and mortality in compensated cirrhosis type C: a retrospective follow-up study of 384 patients","volume":"112","author":"Fattovich","year":"1997","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2006.08.020_bib14","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1136\/gut.2003.038257","article-title":"Long term clinical outcome of chronic hepatitis C patients with sustained virological response to interferon monotherapy","volume":"53","author":"Veldt","year":"2004","journal-title":"Gut"},{"key":"10.1016\/j.jhep.2006.08.020_bib15","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1053\/gast.2002.34175","article-title":"Rapid suppression of hematopoiesis by standard or pegylated interferon-\u03b1","volume":"123","author":"Peck-Radosavlievic","year":"2002","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2006.08.020_bib16","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1136\/gut.2004.038679","article-title":"International Ascites Club. Sepsis in cirrhosis: report on the 7th meeting of the International Ascites Club","volume":"54","author":"Wong","year":"2005","journal-title":"Gut."},{"key":"10.1016\/j.jhep.2006.08.020_bib17","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1177\/135965350400900417","article-title":"Use of pegylated interferons is associated with an increased incidence of infections during combination treatment of chronic hepatitis C: a side effect of pegylation?","volume":"9","author":"Puoti","year":"2004","journal-title":"Antivir Ther"},{"issue":"Suppl 1","key":"10.1016\/j.jhep.2006.08.020_bib18","first-page":"67","article-title":"Safety of combination interferon alfa-2b\/ribavirin therapy in chronic hepatitis C-relapsed and treatment-na\u0131\u00a8ve patients","volume":"19","author":"Maddrey","year":"1999","journal-title":"Sem Liver Dis"},{"key":"10.1016\/j.jhep.2006.08.020_bib19","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1053\/jhep.2002.36502","article-title":"Neutropenia during combination therapy of interferon alfa and ribavirin for chronic hepatitis C","volume":"36","author":"Soza","year":"2002","journal-title":"Hepatology"}],"container-title":["Journal of Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827806005484?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827806005484?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,9]],"date-time":"2023-05-09T13:19:23Z","timestamp":1683638363000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168827806005484"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,2]]},"references-count":19,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2007,2]]}},"alternative-id":["S0168827806005484"],"URL":"https:\/\/doi.org\/10.1016\/j.jhep.2006.08.020","relation":{},"ISSN":["0168-8278"],"issn-type":[{"value":"0168-8278","type":"print"}],"subject":[],"published":{"date-parts":[[2007,2]]}}}